Print
Email
Print Edition StoriesWednesday, February 3, 2010
HeartWare completes $80M offering
By Mass High Tech staff
MHT's Jackie Noblett: VC funds run short in 2009
MHT's Galen Moore: Six Mass. tech firms head to world economic forum
Rodney Brown on NECN: Hacking into medical devices
Framingham medical devices firm HeartWare International Inc. has completed its public stock offering, pulling in a total of $70.9 million.
The company sold almost 1.8 million shares of common stock, including an additional 230,595 shares to cover over-allotments, at $35.50 per share. HeartWare announced the pricing of the stock sale last week.
Net proceeds from the stock offering will be directed to working capital and general corporate purposes.
J.P. Morgan Securities Inc. served as the sole book-running manager of the offering, with Canaccord Adams, Lazard Capital Markets and Wedbush PacGrow Life Sciences as the co-managers.
HeartWare (Nasdaq: HTWR) makes miniature implantable cardiac pumps, called left ventricular assist devices, to treat patients suffering from advanced heart failure.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
